Literature DB >> 14557053

Huntington's disease: a synaptopathy?

Jia-Yi Li1, Markus Plomann, Patrik Brundin.   

Abstract

Huntington's disease (HD) is caused by a polyglutamine expansion in the protein huntingtin. In its terminal stage, HD is characterized by widespread neuronal death in the neocortex and the striatum. Classically, this neuronal death has been thought to underlie most of the symptoms of the disease. Accumulating evidence suggests, however, that cellular dysfunction is important in the pathogenesis of HD. We propose that specific impairment of the exocytosis and endocytosis machinery contributes to the development of HD. We also suggest that abnormal synaptic transmission underlies the early symptoms of HD and can contribute to the triggering of cell death in later stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557053     DOI: 10.1016/j.molmed.2003.08.006

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  56 in total

Review 1.  Staying connected: synapses in Alzheimer disease.

Authors:  Hyoung-Gon Lee; Paula I Moreira; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 2.  No longer falling on deaf ears: mechanisms of degeneration and regeneration of cochlear ribbon synapses.

Authors:  Guoqiang Wan; Gabriel Corfas
Journal:  Hear Res       Date:  2015-04-30       Impact factor: 3.208

3.  Using Huntingtin Knock-In Minipigs to Fill the Gap Between Mouse Models and Patients with Huntington's Disease.

Authors:  Xiangqian Liu; Ting Peng; He Li
Journal:  Neurosci Bull       Date:  2018-08-20       Impact factor: 5.203

Review 4.  PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.

Authors:  Zhengxin Cai; Songye Li; David Matuskey; Nabeel Nabulsi; Yiyun Huang
Journal:  Neurosci Lett       Date:  2018-07-31       Impact factor: 3.046

5.  GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors.

Authors:  Catarina A R V Gomes; Patrícia F Simões; Paula M Canas; César Quiroz; Ana M Sebastião; Sergi Ferré; Rodrigo A Cunha; Joaquim A Ribeiro
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

6.  Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.

Authors:  J Spampanato; X Gu; X W Yang; I Mody
Journal:  Neuroscience       Date:  2008-09-18       Impact factor: 3.590

7.  Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease.

Authors:  Jennifer L Wacker; Shao-Yi Huang; Andrew D Steele; Rebecca Aron; Gregor P Lotz; QuangVu Nguyen; Flaviano Giorgini; Erik D Roberson; Susan Lindquist; Eliezer Masliah; Paul J Muchowski
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

8.  Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease.

Authors:  Svetlana Sarantseva; Svetlana Timoshenko; Olga Bolshakova; Eugenia Karaseva; Dmitry Rodin; Alexander L Schwarzman; Michael P Vitek
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

Review 9.  Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.

Authors:  Carlos Cepeda; Damian M Cummings; Véronique M André; Sandra M Holley; Michael S Levine
Journal:  ASN Neuro       Date:  2010-04-07       Impact factor: 4.146

10.  Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors.

Authors:  M Futter; H Diekmann; E Schoenmakers; O Sadiq; K Chatterjee; D C Rubinsztein
Journal:  J Med Genet       Date:  2009-05-17       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.